|
|
|
|
|
by thebigspacefuck
2328 days ago
|
|
If you look at the case study of the first patient in the US from New England Journal of Medicine the patient didn’t get to a poor condition until day 11 of the illness https://www.nejm.org/doi/full/10.1056/NEJMoa2001191 at which point they tried an experimental antiviral and he recovered. 11 days ago, there were 527 cases. Patient in study didn’t come in until 2 days after having the sickness so if you look at -9 days infected was at 943. Currently at 305 deceased and 443 recovered, total of 748, so it seems like the infected between 9 and 11 days ago are the ones recovering or dying. The number of infected goes up rapidly from that point (now we are at over 16x number of infected from 9 days ago), so we’ll see the numbers get more accurate soon. Although number of cases rapidly increases, the antiviral treatments seem to help dramatically and they have just begun to start experimenting with them. Currently sitting at 40% mortality using D/D+R, but I imagine we’ll see more recoveries as antivirals are used. |
|
I think this is born out by the really small number of children showing up in the mortality numbers. Proportionally, kids usually over-represent transmission, I think, from kid-level hygiene and being crowded into small classrooms. They seem under-represented in the study population, which makes me think there could be a lot of selection bias being captured.
Additionally, the standard for recovery is really high and is built in a way that it will severely lag deaths (which have no waiting period). I think it was something like total clearance of the virus, not "feels good, now surfs reddit all day."